Hang Lu is an Associate Professor in the Department of Communication and Media at the University of Michigan's College of Literature, Science, and the Arts. He specializes in science, health, environmental, and risk communication (ComSHER), with a focus on media psychology. His research explores audience responses to media messages about sensitive topics and strategies to enhance message effectiveness. Lu holds a Ph.D. in Communication from Cornell University (2018), along with advanced degrees from Cornell, Marquette University, and Central South University in China. He directs the Media and Risk (MaR) Lab and previously served as a postdoctoral fellow at the Annenberg Public Policy Center. His research spans four main areas: 1) emotion dynamics in media responses, 2) predictors of information behaviors, 3) media effects on stigmatization, and 4) AI applications in sensitive domains. He has published in journals like Journal of Communication , Risk Analysis , and Public Understanding of Science , earning multiple top paper awards. As Vice Chair of the Environmental Communication Division at the International Communication Association, Lu contributes to interdisciplinary dialogue. His work addresses critical societal issues such as climate change communication, vaccination hesitancy, and emerging technology ethics.
Dr. Vikas Srivastava is an Associate Professor of Engineering and Director of the Graduate Program in Biomedical Engineering at Brown University's School of Engineering. His research focuses on solid mechanics, continuum biomechanics, and cell mechanics, with applications in materials under extreme environments and biomedical science. He leads the Srivastava Lab for Solid Mechanics and Biomechanics, which integrates computational models with experimental techniques to address interdisciplinary challenges. Dr. Srivastava holds a Ph.D. in Mechanical Engineering from MIT (2010) and previously held senior roles at ExxonMobil, including leadership in materials mechanics and deepwater drilling engineering. His academic career at Brown began in 2018, during which he has directed over 15 graduate students and secured notable funding. His research interests span mechanobiology, hydrogel-based drug delivery systems, AI-driven predictive modeling, and biomaterial innovations for cancer therapies. He has pioneered physics-informed neural networks for material characterization and developed novel hydrogels to enhance chemotherapy efficacy. Recent articles highlight advancements in polymer fracture modeling, machine learning for non-destructive evaluation, and predictive epidemiological modeling for pandemics. Dr. Srivastava has received the Dean’s Award in Bioengineering and was promoted to tenured Associate Professor in 2023. He actively mentors students through grants like the NSF Graduate Research Fellowship and leads initiatives in biomedical technology translation. The Srivastava Lab collaborates extensively across engineering, biology, and medicine to advance translational research in materials science and clinical applications.
Dr. Tonghui Jin serves as a Researcher at ETH Zurich's Institute of Food, Nutrition and Health within the Department of Health Sciences and Technology. Based at the Laboratory of Food & Soft Materials (Schmelzbergstrasse 9, Zürich), her work bridges fundamental protein science with industrial applications in sustainability and healthcare. Her research centers on amyloid fibril engineering for multifunctional biomaterials, with three core thrusts: Environmental Solutions : Developing amyloid-based membranes for PFAS water remediation and amine-functionalized aerogels for CO2 capture Biomedical Innovation : Creating microneedle patches for diabetic wound healing and toxin-responsive nanovaccines against bacterial infections Advanced Materials : Engineering structural color systems from amyloid liquid crystals and superwetting functional coatings These efforts leverage protein nanofibrils' unique mechanical and catalytic properties to address global challenges in resource recovery and health. Analysis of her 2021-2025 publications reveals a strategic shift toward catalytic amyloid hybrids, with 60% of recent work focusing on CO2 conversion, lithium recovery, and enzymatic detoxification. The interdisciplinary nature spans materials chemistry, environmental engineering, and biotechnology, demonstrating consistent innovation in converting amyloid polymorphism into functional platforms. No scientific awards were documented in available sources. Dr. Jin contributes to ETH Zurich's Laboratory of Food & Soft Materials, which investigates protein-based soft matter systems for sustainable food and health applications. The lab specializes in fibrillar material assembly, with current projects targeting circular economy solutions through bio-based material design.
Alison Galvani is the Burnett and Stender Families Professor of Epidemiology at Yale School of Public Health and Yale School of Medicine, where she serves as founding director of the Center for Infectious Disease Modeling and Analysis (CIDMA). Her interdisciplinary work bridges epidemiology, evolutionary ecology, and health economics to inform public health policies for diseases including HIV, Ebola, influenza, and COVID-19. Her research focuses on optimizing vaccination strategies and healthcare interventions through mathematical modeling. Recent studies examine SARS-CoV-2 transmission dynamics, RSV vaccine impact, and integration of social determinants into infectious disease models. She has pioneered frameworks for conflict-induced migration analysis and pharmaceutical policy evaluations. Notable scientific awards include the Bellman Prize, Blavatnik Award for Young Scientists, and Guggenheim Fellowship. Her publications span top journals like The Lancet , Nature Communications , and PNAS , with media coverage in major outlets and policy references.
Cecilia Leal is a Professor and Racheff Faculty Scholar in the Department of Materials Science and Engineering at the University of Illinois at Urbana-Champaign, with additional appointments at the Carle Illinois College of Medicine, Materials Research Laboratory, and Beckman Institute. Her interdisciplinary research program bridges materials science, biophysics, and medicine to develop innovative therapeutic delivery systems. Dr. Leal's research focuses on the self-organization of biomolecular systems, particularly lipid membranes, peptides, and nucleic acids. Her lab investigates how structural complexity of lipids and bio-membranes relates to disease mechanisms and informs the design of better gene and drug delivery systems. Key projects include developing lipid nanoparticles for mRNA delivery, studying polymer-lipid hybrid membranes, and characterizing lipid droplet dynamics in metabolic diseases. The lab employs advanced techniques including Small Angle X-ray Scattering, Cryo-EM, and live cell imaging. Her recent publications (2023-2025) reveal a strong emphasis on lipid-based delivery systems for mRNA therapeutics and cancer treatment, with particular attention to how nanostructure affects delivery efficiency. The research spans from fundamental biophysics of lipid-polymer interactions to applied therapeutic development, demonstrating consistent translation of basic science to medical applications. University of Illinois Provost's Distinguished Promotion to Full Professor Award (2024) University of Illinois Scholar (2023) NIH New Innovator Award (2016) NSF CAREER Award (2016) Racheff Faculty Scholar Award (2019) Dr. Leal has mentored numerous graduate students and postdocs, many now in prominent positions at MIT, Stanford, Dow Chemical, and pharmaceutical companies. Her research is supported by multiple NIH and NSF grants, and she maintains active collaborations with medical researchers studying obesity, cancer, and respiratory diseases. She teaches core courses including MSE 201 (Phases and Phase Relations) and MSE 473 (Biomolecular Materials Science), consistently earning excellent teaching ratings. The Leal Lab operates as an interdisciplinary team of materials scientists, physicists, and chemists using cutting-edge characterization tools to solve biomedical challenges. The lab's work on lipid nanoparticle structure has direct relevance to next-generation mRNA vaccines and cancer therapies, with several publications highlighted in C&EN News and other prominent scientific media.
Dr Jonathan Cook is a Research Fellow at Jesus College, University of Oxford, affiliated with the Medical Sciences division. He holds a primary medical qualification from Queen’s University (Canada, 2021) and a PhD investigating viral immune evasion mechanisms under Prof Jeffrey Lee. His work was supported by the Vanier Canada Graduate Scholarship and recognized with the Stuart Alan Hoffman Memorial Prize. As an incoming Banting Fellow at the Jenner Institute, he focuses on vaccine design for infectious diseases. His research interests include malaria eradication, emerging pathogens, and structure-based vaccine strategies. **Education**: - PhD (Investigation of viral entry glycoproteins), University of Toronto, supervised by Prof Jeffrey Lee - Primary Medical Qualification, Queen’s University, Canada **Research Interests**: - Malaria Eradication : Developing vaccines targeting Plasmodium species. - Emerging Infectious Diseases : Designing rapid-response strategies for pathogens like SARS-CoV-2. - Structure-Based Vaccine Design : Leveraging protein structural data to enhance immunogenicity. **Awards**: - Vanier Canada Graduate Scholarships Programme (2017–2020) - Stuart Alan Hoffman Memorial Prize (2021) - Banting Fellowship (incoming) **Grants/Advising**: Works on Jenner Institute-funded projects. No listed advisees yet. **Labs/Teams**: Collaborates with Prof Lee's lab at the Jenner Institute and the University of Toronto's Medical Microbiology program.
Maartje Bastings is an Associate Professor at the École Polytechnique Fédérale de Lausanne (EPFL) , leading the Programmable Biomaterials Laboratory (PBL) within the School of Engineering (STI) . She holds additional affiliations with the Institute of Materials (IMX) , IBI-STI (Bioengineering), and supervises doctoral programs in Biotechnology and Biological Engineering ( EDBB-GE ) and Materials Science and Engineering ( EDMX-GE ). Her research focuses on DNA-based supramolecular materials engineered to achieve dynamic reciprocity —a two-way interaction between synthetic materials and biological systems. By leveraging DNA as a programmable scaffold, she investigates structural mechanics, valency control, and geometric constraints governing self-assembly and cell communication at bio-interfaces. Key applications include immune system modulation, diagnostics , and vaccine development . Analysis of her 15 most recent publications reveals a focus on multivalent interactions for T-cell activation, spatial patterning in immune signaling, and engineered coatings for DNA origami stability. Subfields span T cell receptor engineering , nanoscale protein dynamics , stimuli-responsive biomaterials , and bio-inspired therapeutic design . PhD Students: Chen Yuduo Hendrickx Pauline Bart M. Kononenko Artem Li Shujie Lou Yameng Meyer Pitt Narita Minako Rousseau Benjamin Bila Hale Caroprese Vincenzo Comberlato Alice Kurisinkal Eva Eugene Paloja Kaltrina Rodríguez Franco Hugo José Tekin Cem Wong Siu Ho Contact: maartje.bastings@epfl.ch
Professor Roland J. Pieters is a distinguished academic at Utrecht University's Faculty of Science, where he serves as a full Professor in the Department of Chemical Biology and Drug Discovery. With over two decades of experience at the institution, he has progressed from Assistant Professor (1998) to Associate Professor (2005) and ultimately to Full Professor (2010-present). His research group is internationally recognized for groundbreaking work at the intersection of carbohydrate chemistry, chemical biology, and drug discovery, with particular emphasis on developing novel therapeutic approaches against bacterial infections and pathogenic mechanisms. Full Professor, Utrecht University (2010-present) Associate Professor, Utrecht University (2005-2010) Assistant Professor, Utrecht University (1998-2005) NWO Talent Post-doctoral Fellow, ETH-Zürich (1995-1996) Postdoctoral Researcher, University of Groningen (1996-1998) Professor Pieters earned his M.Sc. in Organic Chemistry from the University of Groningen in 1990, where he worked with Professor Ben Feringa, and completed his Ph.D. at MIT in 1995 under the supervision of Professor Julius Rebek Jr. His doctoral research focused on molecular recognition and template effects in bisubstrate systems, establishing the foundation for his lifelong interest in molecular interactions. Professor Pieters' research primarily centers on glycodrugs and the strategic interference with protein-carbohydrate interactions using multivalent systems of varying architectures. His laboratory has made significant contributions to understanding how rigid spacers in multivalent ligands can dramatically enhance binding affinity to target proteins, with applications against viral and bacterial adhesion proteins, toxins, galectins, and glycosidases. A particular focus has been on developing inhibitors for Pseudomonas aeruginosa lectin LecA, cholera toxin, influenza virus hemagglutinin, and more recently, SARS-CoV-2 spike protein interactions with host cell receptors. His group also pioneered the use of glyco- and peptide-microarrays for high-throughput screening of carbohydrate-protein interactions and drug discovery, particularly in the area of O-GlcNAcylation research. The publication record of Professor Pieters demonstrates consistent innovation in the field of multivalent carbohydrate-based therapeutics. His recent work (2020-2024) shows a strategic expansion into viral pathogenesis (particularly influenza and SARS-CoV-2), immune modulation through glycan recognition, and novel approaches to vaccine development. A notable trend is the increasing sophistication of multivalent architectures, moving from simple divalent systems to tetra- and hexavalent ligands with precisely engineered spatial arrangements. His research bridges fundamental chemical principles with practical therapeutic applications, maintaining strong connections to pharmaceutical development while advancing basic science understanding of carbohydrate-mediated biological processes. Professor Pieters' scientific achievements have been recognized with prestigious awards including a Fellowship from the Royal Netherlands Academy of Arts and Sciences (KNAW) in 1999 and a VICI personal grant from the Netherlands Organisation for Scientific Research (NWO) in 2008. These competitive awards reflect the significance and innovation of his research program. He has also served on editorial advisory boards, notably as Section Editor-in-Chief for Chemical Biology in the journal Molecules (2018-2022), contributing to the scholarly community through peer review and academic leadership. Fellowship of Royal Netherlands Academy of Sciences (KNAW), 1999 VICI, personal grant, NWO, 2008 Section Editor-in-Chief Chemical Biology for Molecules (2018-2022) Throughout his career, Professor Pieters has coordinated significant research projects including the EU project POLYCARB and secured competitive funding that has sustained his innovative research program. His laboratory has fostered numerous collaborations across Europe and internationally, creating a vibrant research environment that has trained many scientists now working in academia and industry. His research on multivalent carbohydrate systems represents a sustained intellectual contribution to chemical biology with direct relevance to developing new anti-infective strategies and therapeutic approaches. Professor Pieters leads an active research group within Utrecht University's Department of Chemical Biology and Drug Discovery, situated in the David de Wied Building. His laboratory maintains strong connections with other research groups both within Utrecht University and internationally, particularly in the fields of glycobiology, infectious diseases, and drug discovery. The research environment he has cultivated emphasizes interdisciplinary approaches, combining synthetic chemistry, biophysical analysis, and biological testing to address fundamental questions in carbohydrate-mediated biological processes with therapeutic applications.
Dr. Ed E. Moret is an Associate Professor of Computational Medicinal Chemistry at Utrecht University, where he serves as Managing Director of the Utrecht Institute for Pharmaceutical Sciences. He is a member of the Departmental Executive Board and Chair of the Board of Examiners of the School of Pharmacy. His academic career spans over three decades with significant contributions to pharmaceutical sciences. Utrecht University, Utrecht Institute for Pharmaceutical Sciences School of Pharmacy, Department of Chemical Biology and Drug Discovery Managing Director since January 2010 Dr. Moret's educational background includes completing Gymnasium-b at Gymnasium Camphusianum in Gorinchem in 1979, followed by pharmacy studies at Utrecht University until 1988. He earned his PhD in 1993 with research on calculations and simulations of DNA-alkylating cytostatics under supervision of Prof. L.H.M. Janssen and Prof. J.P.A.E. Tollenaere. He also conducted postdoctoral research at the Scripps Research Institute with Prof. A.J. Olson. His primary research interests focus on molecular recognition, particularly in auto-immune diseases, with expertise spanning computational medicinal chemistry, computer-aided drug discovery, cheminformatics, and bioinformatics. Dr. Moret's work bridges the gap between theoretical calculations and experimental validation in drug design. His research portfolio demonstrates a consistent trajectory from fundamental molecular interactions to applied drug discovery, with particular emphasis on enzyme inhibitors, carbohydrate-protein interactions, and molecular recognition processes. Analysis of his publication record reveals a strong focus on structure-based drug design, with significant contributions to the development of inhibitors for enzymes like β-glucocerebrosidase, NNMT, and neuraminidase. His work spans multiple therapeutic areas including lysosomal storage disorders, cancer metabolism, and infectious diseases. The interdisciplinary nature of his research is evident in the integration of computational approaches with experimental validation across biochemistry, pharmacology, and medicinal chemistry. Teacher of the Year (awarded three times by Pharmacy students) Member of editorial boards for Medicines and Conceptuur journals Secretary of Board of FIGON (2016) Secretary of Raad voor de Farmaceutische Wetenschappen (2024) Member of Board of Stichting Farmaceutische Erfgoed (2024) Dr. Moret has been actively involved in educational innovation, developing and coordinating the master's programme Drug Innovation, the profile Drug Regulatory Sciences, and the Honours programme Pharmaceutical Sciences. He has taught courses for pharmacy, chemistry, UCU and medical sciences students, as well as PhD courses in bioinformatics and computer-aided drug discovery. His educational contributions include developing an inquiry-based elective course on drug discovery, for which he published educational research. He holds BKO and SKO teaching qualifications and participated in the Centre of Excellence in University Teaching program. As Managing Director of the Utrecht Institute for Pharmaceutical Sciences, Dr. Moret leads research initiatives across chemical biology, drug discovery, and pharmaceutical sciences. His leadership extends to multiple advisory and editorial roles within the pharmaceutical research community, reflecting his significant contributions to both academic and professional spheres of pharmaceutical sciences.
Anne Berit C. Samuelsen serves as Associate Professor at the Department of Pharmacy, University of Oslo, where she also holds the position of Head of Education. Her academic foundation includes a Cand.pharm. degree and Dr.scient. doctorate, establishing her expertise in pharmaceutical sciences. Her research centers on polysaccharides from natural sources—particularly higher plants, cereals, and fungi (Basidiomycota)—with specialized focus on β-glucans. Key interests include carbohydrate chemistry, pharmacognosy, and the development of biopolymer-based pharmaceutical applications. Her work bridges fundamental structural characterization with practical drug delivery solutions, notably through liposome coating technologies and immunomodulatory compound development. Recent publications reveal a strong trajectory in fungal polysaccharide research, particularly with Pleurotus eryngii and Albatrellus ovinus species. Her team employs advanced techniques like diffusion-ordered NMR spectroscopy to analyze polysaccharide structures while investigating biological activities related to immune receptor binding (Dectin-1, Toll-like receptors) and therapeutic applications. This work demonstrates consistent output in high-impact journals including Carbohydrate Polymers and ACS Applied Bio Materials . She actively contributes to academic instruction through courses such as FARM1150 (Pharmaceutically Oriented Biochemistry), FARM3100 (Pharmacognosy), and FARM5200 (Use of Biopolymers in Pharmaceuticals). Her leadership extends to the Bioactive Natural Substances and Health Effects (BioNatH) research group and the Glyconor Consortium, where she investigates natural product applications for health improvement.
Prof. Dr. Urs Fischbacher is a full-time Professor at the Department of Economics at the University of Konstanz, holding the Chair of Behavioral Economics. He is also affiliated with the Thurgau Institute of Economics in Switzerland. Research Focus: Behavioral Economics, Experimental Economics, Game Theory, Social Preferences, Public Goods, Trust and Cooperation, Decision-Making under Stress, and Neuroeconomics. Key Projects: Evaluation of educational interventions in Colombia, analysis of leadership selection in inequality perception, and studies on social pension targeting in Bangladesh. Academic Contributions: His recent articles focus on super-additive cooperation mechanisms, responsibility attribution in decision chains, stress-induced prosociality, and diversity policy impacts. Work spans interdisciplinary collaborations with psychologists and neuroscientists. Contact: Based at the University of Konstanz (Room F315) and Thurgau Institute of Economics. Office hours require appointment via email.
Ulla-Mari Kinnunen is a Professor of Health and Human Services Informatics at the University of Eastern Finland's Department of Health and Social Management, within the Faculty of Social Sciences and Business Studies. She also holds the title of Adjunct Professor in Evidence-Based Research and Development. Her research focuses on health informatics, digitalization in healthcare and social services, evidence-based practices, and informatics competencies for professionals and citizens. She chairs the Finnish nursing terminology (FinCC) and serves on the IMIA Nursing Informatics Board and the Finnish Centre for Evidence-Based Health Care. She supervises 16 doctoral students and coordinates the Health and Human Services Informatics (HHSI) Master’s program. She is a member of the Finnish Publication Forum (Panel 14) and the Editorial Board of JMIR Nursing. In 2021, she was awarded the IMIA fellowship as a Fellow of the International Academy of Health Sciences Informatics. Her research interests include structured data systems, classifications in electronic health records (EHR), and organizational factors influencing digitalization. Key projects include the 'FinCC' research group for nursing terminology and the 'House of Effectiveness' initiative. Her work emphasizes improving healthcare quality through informatics and evidence-based practices. Recent publications highlight studies on information systems implementation, digitalization challenges, and the role of informatics in interprofessional collaboration. She actively contributes to international health informatics education and policy, including the European Summer School in Health Informatics and the TIGER Initiative for workforce development. Grants and Projects: Research Project on Data Resources for Fire Investigation (2023–2025), IMIA Fellowship, and EU-funded initiatives like eHealth4all@eu. Labs/Teams: Health and Human Services Informatics Research Group, FinCC Research Group, and the Finnish Centre for Evidence-Based Health Care.
Yan Liu is a Senior Lecturer in Glycosciences at Imperial College's Department of Metabolism, Digestion and Reproduction (Faculty of Medicine). She leads the Wellcome Trust-funded Carbohydrate Microarray Facility and co-leads the GlycoTWINNG Network. Her research focuses on glycan-mediated interactions in host-microbiota interfaces, with applications in infectious diseases and reproductive health. She holds a B.Sc. from Peking University and a Ph.D. from the University of Bristol, followed by postdoctoral work at Imperial College under Professor Ten Feizi FRS. Her academic journey includes roles as a Microarray Project Leader and co-investigator in the March of Dimes European Preterm Birth Research Centre. She is PI of a £1.34M Wellcome Trust grant maintaining Imperial's Carbohydrate Microarray Facility, advancing glycan array technologies. Research interests span microbiology, immunology, and biomolecular chemistry, with a focus on glycobiology. Key contributions include defining glycan interactions in pathogen-host systems (e.g., Candida albicans, adenoviruses), developing glycan probes, and analyzing vaginal microbiota impacts on preterm birth. Grants and collaborations include EPSRC Translational funding and the UK 'FluTrialMAP' consortium. Labs affiliations include the Glycosciences Laboratory and Imperial's Institute of Infection.
Kathleen O'Connor Duffany, PhD, MEd, is an Associate Professor of Public Health in the Department of Social and Behavioral Sciences at the Yale School of Public Health . She serves as Director of Research and Evaluation at the Community Alliance for Research and Engagement (CARE) and Co-Director of the Yale-Griffin Prevention Research Center . Her work focuses on dismantling structural barriers to health equity through community-engaged research and policy advocacy. PhD in Chronic Disease Epidemiology/Social and Behavioral Sciences (2015), Yale School of Public Health MEd in Elementary and Special Education (1995), Boston College BA in Psychology and English (1991), College of the Holy Cross Dr. Duffany leads community-based participatory evaluations across diverse public health domains including food insecurity, breastfeeding support, maternal-child health, and vaccine equity. She directs the Community Impact Lab , which connects students with local organizations for equitable practice partnerships, and provides technical assistance for health departments statewide. Her research emphasizes translating findings into policy solutions through coalition-building and structural interventions. Recent publications demonstrate expertise in produce prescription programs , nutrition interventions in food pantries , and equity-focused workforce development . She has published extensively on health disparities in Frontiers in Public Health , Maternal and Child Nutrition , and International Journal of Environmental Research and Public Health , with methodological strengths in qualitative evidence synthesis and community-clinical linkages . Current projects examine person-centered food assistance models and structural determinants of mental wellbeing . At Yale, she teaches Community Health Program Evaluation to MPH and PhD students and leads annual Evidence-Based Public Health trainings for Connecticut health professionals. Her leadership roles include mentoring Vaccine Equity Fellows and directing formative evaluations of statewide health initiatives.
Masaru Kohno is a Professor at the Faculty of Political Science and Economics at Waseda University, with a career spanning over two decades. His research focuses on Japanese politics , electoral studies , and international relations , often employing experimental methods and cross-national comparisons. He has held visiting and research positions at institutions like Stanford University, University of British Columbia, and Sophia University. Education : Ph.D. in Political Science (Stanford University), MA in International Relations (Yale University), LL.B. (Sophia University) His recent work includes experimental analyses of foreign aid preferences, hate speech regulation, and electoral strategies. He has received grants from the Japan Society for the Promotion of Science and contributed to debates on democratic accountability, policy networks, and post-COVID governance. Kohno has presented at leading conferences such as the American Political Science Association and International Political Science Association, often collaborating with scholars like Matthew S. Winters and Gabriella R. Montinola. Key Research Areas : Electoral systems and strategic voting Public opinion on foreign policy Political economy of institutions Democratic accountability mechanisms
